Insider trade

Bristol Myers Squibb (BMY)Officer bought ~$100K

Samit Hirawat, Officer at Bristol Myers Squibb, bought ~$100K of Bristol Myers Squibb shares.

~$100K
Approx. value · 1,823.49 sh @ $54.84: 64K
Holds after · shares reported

Traded: Feb 14, 2025
Filed: Feb 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Dec 6, 2024CongressDisclosed purchase of BMY — reported range $1,001 - $15,000
Dec 27, 2024FDAFDA drug approval: Opdivo Qvantig
Dec 27, 2024FDAFDA drug approval: Opdivo Qvantig
Jan 15, 2025CongressDisclosed purchase of BMY — reported range $1,001 - $15,000
Jan 28, 2025FDAFDA drug approval: Yervoy
Feb 14, 2025 · this disclosureInsiderOfficer purchased ~$100K of BMY shares in the open market

What came next

Feb 20, 2025InsiderCEO purchased ~$110K of BMY shares in the open market
Mar 27, 2025CongressDisclosed sale of BMY — reported range $1,001 - $15,000
Apr 1, 2025CongressDisclosed sale of BMY — reported range $1,001 - $15,000
Apr 8, 2025FDAFDA drug approval: Opdivo
Apr 8, 2025FDAFDA drug approval: Yervoy
Apr 11, 2025FDAFDA drug approval: Opdivo
Apr 11, 2025FDAFDA drug approval: Yervoy
Apr 15, 2025CongressDisclosed sale of BMY — reported range $1,001 - $15,000
Apr 17, 2025FDAFDA drug approval: Eliquis
Apr 17, 2025FDAFDA drug approval: Eliquis
Apr 25, 2025InsiderOfficer purchased ~$202K of BMY shares in the open market
May 2, 2025Layoff notice · 1930 & 1950 Innovation Way, 1900 & 1940 USG Dr., LibertyvilleLayoff notice filed in IL: 133 employees
May 9, 2025InsiderOfficer sold ~$3.7K of BMY shares in the open market
May 23, 2025FDAFDA drug approval: Opdivo
May 23, 2025FDAFDA drug approval: Yervoy

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Bristol Myers Squibb

For Bristol Myers Squibb, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 45 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BMY page.

Other recent filings by Samit Hirawat, EVP,Chief Med.Offr.,Drug Dev.

The full history of Samit Hirawat, EVP,Chief Med.Offr.,Drug Dev. is on the profile page.

How this filing works

Other disclosures at Bristol Myers Squibb

Everything OQRO holds on this company is on its BMY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data